Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 

Letter From The Editor

Editor's Note, DCMS #176: Setting Targets Too High

Most of us who treat diabetes patients know that the hardest part is getting patients to make positive changes. We often set the targets so high that patients just give up. If you take a careful look at our Homerun Slides from Dr. Stanley...


Letter from the Editor #716:

According to an article in the Consumer Electronics Association newsletter this week, the shipments of wearable bands including smart watches and fitness trackers are forecast to exceed more than 17 million units this year. The smart band...


Editor's Note, DCMS #175: Dr. Sheri Colberg

Most of you are very familiar with Dr. Sheri Colberg. She has been sharing her wisdom with us for many years and just last Saturday she shared



Letter from the Editor #715:

Many times our patients will say "just give me a book I can read that will fix all my problems and I will do it," and we know full well that it will most likely never happen. Over the years I have recommended a few but the patients could...


Editor's Note:

While I was enjoying the 80 degree weather in Florida, our publisher kept wishing the thermometer would get up to zero in Chicago. Even though it is bitterly cold in those northern places, patients still bundle up, put on their warmest boots and...


Letter from the Editor, #714: Diabetes Optimal Care Not Cost Effective

This week was not a good one in our area for getting an appointment with an endocrinologist. Most of our endo's are over 60 years old and we have only had two new endocrinologists come into the area in the past four years. What makes it harder is...


Editor's Note, DCMS #173:

We often hear about the idea of a medical care plan. My interns come to me all full of vim and vigor, and ready to do a plan on any person who presents with diabetes. However, this is hard when you have to take into account insurance plans, patient...


GLP-1 Special Editions, January 2014

As we move into the ninth year that GLP-1 analogs have been available many of you have taken advantage of this class of medications for your patients. Every day more prescriptions are being filled and patients are learning the value of non-insulin...


Letter from the Editor #713:

Now that we have a second SGLT-2 inhibitor on the market we are seeing other companies trying to be the newest "me too's" on the block. Prescriber acceptance of this class is growing and so it only makes sense that more companies will try...


Editor's Note, DCMS #172: 'Sedentarism'

Each year there is a contest to find out which new word added to the dictionary is the most popular. Many of you know that the winner this year was 'selfie', a self-taken picture which gets posted on Facebook and other social media sites. But when...


Editor's Note, SGLT2 Inhibitors Special Editions, January 2014

I was talking to a physician recently when the topic of SGLT2 inhibitors came up. He spoke about his experience with the drugs and how he felt that a lot of physicians had a negative feeling about the drug because of the chance of UTI's. He felt...


Letter from the Editor #712:

This past week, I was in an office in St. Petersburg seeing patients and almost all of them were on insulin. In fact they were either on Reg and NPH, or 70/30 lin mix. I have always believed that for most type 2 patients who don't count carbs or use...


Editor's Note, DCMS #171: Dapagliflozin Approval

Last Friday, the FDA approved the SGLT2 inhibitor dapaglifozin. This is the second drug...


Letter from the Editor, #711: CES, Forxiga, and Keeping New Year's Resolutions

I am at the annual Consumer Electronics Show in Las Vegas this week and it is easy to see how technology is moving into the healthcare segment. Three years ago, less than 2% of the booths were dedicated to health and wellness -- this year, a full...


Editor's Note, DCMS #170:

As soon as someone with diabetes goes in the hospital they are usually put on insulin. Since many of the patients have been insulin naive or only on long-acting insulin the introduction of R or analog insulins can often be problematic. In part six...


Letter from the Editor, #710:

The new year is finally here which means the Affordable Care Act started this past Wednesday. The start-up has been fraught with computer problems, misrepresentations, and half-truths from all sides of the political spectrum. As a medical...


Editor's Note, DCMS #169

What would you do if you had a patient with type 1 diabetes, unusual fatigue, weight gain, and an A1c 1.3% higher than her previous one? If it was weight gain and a lower A1c it might mean one thing; higher A1c and lower weight would mean...


Letter from the Editor #709:

Happy Holidays from all of us at Diabetes In Control.   As I was reviewing the articles for this week I got a call at the pharmacy from a 40 year old patient asking me to refill her two diabetes drugs:...


Editor's Note, DCMS #168: How Pharmacists Can Help Reduce Hospital Errors

Studies have shown that, on average, 54% of patients experience some type of error in medication reconciliation in the hospital. This leads to all kinds of problems as often these patients are prescribed hospital meds with no way to know if...


Letter from the Editor #708:

As we come to the holiday season there is a lot to be thankful for but some people are going to have a lot better Christmas than others. These "lucky schemers" have figured out a way to make millions by defrauding the Medicare Part D dry...


Editor's Note, DCMS #167:

Most of the time when we see our type 2 patients we look at the excess fat hanging over their belts and wish we could just get them to lose this useless mass of stored calories. However, based on what Dr. Osama Hamdy, MD, PhD, FACE, has found, we...


Letter from the Editor, #707:

Last month many of you took the time to read and print our column from Dr. Sheri Colberg on exercises for older adults....


SGLT2 Inhibitor Special Edition, Issue #9

In our last newsletter of the year on SGLT2 inhibitors we are going to look forward to what is in store for 2014 and beyond. This month, our PharmD candidate, Heather Good, has prepared a special feature on the how this class will expand and how...


Editor's Note, DCMS #166:

The FDA does not often reverse their decision on a medication but that has now happened with Avandia. With clinicians potentially using this TZD again, it's a good time to revisit one of the most common errors from the past. The ISMP has had...


Letter from the Editor #706:

On Thursday night I was presenting a program on insulin to medical professionals and I asked the participants how a patient could go to bed with a normal glucose but wake up with a higher glucose in the morning. I heard words like...


Editor's Note, Type 2 Diabetes Special Edition #2: Food Label Confusion

I have been providing diabetes education for the last 19 years and over that time there have been so many methods for diabetes control and management that it would fill up a thumb drive to just list all of them. Currently the main focus seems to be...


Editor's Note, Insulin Special Edition #4: Patient Self-titrating and Type 2

Typically we as medical professionals usually postpone our starting of insulin in type 2 patients as long as possible. This has become easier over the past few years as we have had four new classes of medications come into the market in the...


Editor's Note, DCMS #165: Evidence-based Practice

Is there a difference between evidence-based medicine and evidence-based practice? Dr. Stanley Schwartz thinks so and this week we are going to share his Homerun Slides on


Letter from the Editor, #705: Avandia and FDA Approvals

This week the FDA reversed its previous decision on Avandia (see this week's Item #1). All the hype and bad press that Dr. Steven Nissen of the Cleveland...


Editor's Note, DCMS #164: Cystic Fibrosis Slides

Over 30,000 people in the U.S. have cystic fibrosis and there are about 1,000 new cases a year. Most of these are diagnosed by the age of two and during their lifetimes they will need a lot of life-saving meds. Forty years ago the average survival...


Letter from the Editor #704: HealthCare.gov

There has been so much press over the failure of the ACA website that everyone wants to blame someone. You would think that a government that could fly a drone by remote control 11,000 miles away could get this correct. The continued pressure to...


Editor's Note SGLT2-I #8: The Realities of UTI Risk

Last month we talked about how prescribers were getting over their fear of using SGLT2 Inhibitors because of the warning about urinary tract infections. Although incidence in the clinical trials was low there had been an apparent exaggeration in...


Editor's Note, DCMS # 163: Psychological Issues in Diabetes

Have you ever had a day when your patients just drive you crazy? They haven't had their labs done, they didn't get their last prescription filled, or they've forgotten their log books. If you string enough of these patients together, you can end up...


Letter from the Editor #703:

This week there was a change in guidelines concerning the use of cholesterol lowering medications. New guidelines from the American College of Cardiology...


Editor's Note, DCMS #162: Cystic Fibrosis and Diabetes

There are a lot of diseases caused by recessive traits that can be devastating to our patients with diabetes and even a few that can lead to diabetes. None of these are as deadly and well known as Cystic Fibrosis. This week our intern Afshaun...


Letter from the Editor, #702

For the last year we have had a generic version of the alpha glucosidase inhibitor, Acarbose. Many of you would never prescribe this medication because of the possible side effects of gas and gastric discomfort. In addition there did not appear to...


Special Edition: Type 2 Diabetes, Issue #1

Recently, a doctor who I used to do diabetes classes for called me. We had stopped the classes because of a lack of funding and he wanted to start them again. Part of his reason was to help his patients but he also knew that he was now being graded...


Special Insulin Edition #3: Insulin Therapy in Older Adults

I have spent the past couple of weeks preparing a CE webinar for the American Association of Nurse Assessment Coordination. This organization represents long-term care professionals who provide quality care for nursing home residents across the...


Editor's Note, DCMS #161

Over the past few years there has been a decrease in the ability of clinicians to diagnose and treat patients. According to a study in The Lancet, this decrease in diagnostic ability can be partly blamed on the increased use of smartphones...


Letter from the Editor #701

Last week I shared some information on saturated fat in my Letter from the Editor from the BMJ. Many of...



Navigate through our listing of Letter From The Editor articles here.
First Previous Next Last

665 Total articles for Letter From The Editor


Browse our other news categories below.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Looking for a particular Newsletter Issue? Click Here


Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Lynn Grieger, CDE, RD

Category: Nutrition
Credits: .5


Advertisement